Cargando…
Systematic Exposition of Mesenchymal Stem Cell for Inflammatory Bowel Disease and Its Associated Colorectal Cancer
Mesenchymal stem cells (MSCs) therapy has been applied to a wide range of diseases with excessive immune response, including inflammatory bowel disease (IBD), owing to its powerful immunosuppression and its ability to repair tissue lesions. Different sources of MSCs show different therapeutic proper...
Autores principales: | Kang, Jingjing, Zhang, Li, Luo, Xiao, Ma, Xiangyu, Wang, Gaoying, Yang, Yanhui, Yan, Yongmin, Qian, Hui, Zhang, Xu, Xu, Wenrong, Mao, Fei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6327253/ https://www.ncbi.nlm.nih.gov/pubmed/30687760 http://dx.doi.org/10.1155/2018/9652817 |
Ejemplares similares
-
Exosomes Derived from Human Umbilical Cord Mesenchymal Stem Cells Relieve Inflammatory Bowel Disease in Mice
por: Mao, Fei, et al.
Publicado: (2017) -
The Achievements and Challenges of Mesenchymal Stem Cell-Based Therapy in Inflammatory Bowel Disease and Its Associated Colorectal Cancer
por: Ocansey, Dickson Kofi Wiredu, et al.
Publicado: (2020) -
Mesenchymal stem cell–gut microbiota interaction in the repair of inflammatory bowel disease: an enhanced therapeutic effect
por: Ocansey, Dickson Kofi Wiredu, et al.
Publicado: (2019) -
HucMSC‐exosomes carrying miR‐326 inhibit neddylation to relieve inflammatory bowel disease in mice
por: Wang, Gaoying, et al.
Publicado: (2020) -
hucMSCs Attenuate IBD through Releasing miR148b-5p to Inhibit the Expression of 15-lox-1 in Macrophages
por: Kang, Jingjing, et al.
Publicado: (2019)